Codexis Names Georgia Erbez as CFO

Dow Jones

2024-10-02

Codexis0.00%盘后

By Connor Hart

Codexis has named Georgia Erbez as its chief financial officer, succeeding Sri Ryali.

Erbez most recently served as chief operating officer at Walking Fish Therapeutics, a private B-cell therapy company. Prior, she has held executive roles at companies including Harpoon Therapeutics, Zosano Pharma and Revolution Medicines, the enzyme-engineering company said Wednesday.

Codexis also named Alison Moore to the newly-created role of chief technology officer, and named John Schiffhauer as senior vice president of intellectual property.

Also on Wednesday, the company announced an increase in its cash reserves through capital raises totaling $31 million.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

October 02, 2024 16:24 ET (20:24 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

no data

没有相关数据

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2472501339"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2472501339\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2472501339?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-03 04:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2472501339","market":"nz","top_or_hot":-1,"title":"Codexis Names Georgia Erbez as CFO","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/CDXS\">Codexis</a> has named Georgia Erbez as its chief financial officer, succeeding Sri Ryali. \n</p>\n<p>\n  Erbez most recently served as chief operating officer at Walking Fish <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, a private B-cell therapy company. Prior, she has held executive roles at companies including Harpoon Therapeutics, Zosano Pharma and Revolution Medicines, the enzyme-engineering company said Wednesday. \n</p>\n<p>\n  Codexis also named Alison Moore to the newly-created role of chief technology officer, and named John Schiffhauer as senior vice president of intellectual property. \n</p>\n<p>\n  Also on Wednesday, the company announced an increase in its cash reserves through capital raises totaling $31 million. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 02, 2024 16:24 ET (20:24 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Codexis Names Georgia Erbez as CFO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCodexis Names Georgia Erbez as CFO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-10-03 04:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/CDXS\">Codexis</a> has named Georgia Erbez as its chief financial officer, succeeding Sri Ryali. \n</p>\n<p>\n  Erbez most recently served as chief operating officer at Walking Fish <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, a private B-cell therapy company. Prior, she has held executive roles at companies including Harpoon Therapeutics, Zosano Pharma and Revolution Medicines, the enzyme-engineering company said Wednesday. \n</p>\n<p>\n  Codexis also named Alison Moore to the newly-created role of chief technology officer, and named John Schiffhauer as senior vice president of intellectual property. \n</p>\n<p>\n  Also on Wednesday, the company announced an increase in its cash reserves through capital raises totaling $31 million. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 02, 2024 16:24 ET (20:24 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CDXS","symbol_name":"Codexis","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2472501339","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2472501339","pubTimestamp":1727900640,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Codexis has named Georgia Erbez as its chief financial officer, succeeding Sri Ryali.Erbez most recently served as chief operating officer at Walking Fish Therapeutics, a private B-cell therapy company. Prior, she has held executive roles at companies including Harpoon Therapeutics, Zosano Pharma and Revolution Medicines, the enzyme-engineering company said Wednesday.Codexis also named Alison Moore to the newly-created role of chief technology officer, and named John Schiffhauer as senior vice president of intellectual property.Also on Wednesday, the company announced an increase in its cash reserves through capital raises totaling $31 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CDXS":"Codexis","BK4121":"生命科学工具和服务"},"translate_title":"Codexis任命Georgia Erbez为首席财务官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDXS":1},"content_text":"By Connor Hart \n\n\n \n\n\nCodexis has named Georgia Erbez as its chief financial officer, succeeding Sri Ryali. \n\n\n  Erbez most recently served as chief operating officer at Walking Fish Therapeutics, a private B-cell therapy company. Prior, she has held executive roles at companies including Harpoon Therapeutics, Zosano Pharma and Revolution Medicines, the enzyme-engineering company said Wednesday. \n\n\n  Codexis also named Alison Moore to the newly-created role of chief technology officer, and named John Schiffhauer as senior vice president of intellectual property. \n\n\n  Also on Wednesday, the company announced an increase in its cash reserves through capital raises totaling $31 million. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 02, 2024 16:24 ET (20:24 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}

如果下载按钮点击无跳转，请点击右上角菜单选择 “在浏览器打开”

立即咨询
下载APP
扫码下载APP